Strategic Use of Nanotechnology in Drug Targeting and Its Consequences on Human Health: A Focused Review

Overview

Journal Interv Med Appl Sci

Publisher Akademiai Kiado

Specialty General Medicine

Date 2020 Mar 10

PMID 32148902

Citations 11

Authors

Anand Maurya

Anurag Kumar Singh

Gaurav Mishra

Komal Kumari

Arati Rai

Bhupesh Sharma

Giriraj T Kulkarni

Rajendra Awasthi

Affiliations

Soon will be listed here.

Abstract

Since the development of first lipid-based nanocarrier system, about 15% of the present pharmaceutical market uses nanomedicines to achieve medical benefits. Nanotechnology is an advanced area to meliorate the delivery of compounds for improved medical diagnosis and curing disease. Nanomedicines are gaining significant interest due to the ultra small size and large surface area to mass ratio. In this review, we discuss the potential of nanotechnology in delivering of active moieties for the disease therapy including their toxicity evidences. This communication will help the formulation scientists in understanding and exploring the new aspects of nanotechnology in the field of nanomedicine.

Citing Articles

Updates on the conversion of nanosuspensions to solid oral dosage forms.

Tsiaxerli A, Vardaka E, Moutroupidis C, Taylor K, Kachrimanis K, Malamatari M J Food Drug Anal. 2025; 32(4):398-411.

PMID: 39752860 PMC: 11698592. DOI: 10.38212/2224-6614.3525.

Salmon-IgM Functionalized-PLGA Nanosystem for Florfenicol Delivery as an Antimicrobial Strategy against .

Velasquez F, Frazao M, Diez A, Villegas F, Alvarez-Bidwell M, Rivas-Pardo J Nanomaterials (Basel). 2024; 14(20).

PMID: 39452994 PMC: 11510216. DOI: 10.3390/nano14201658.

Nano biomaterials based strategies for enhanced brain targeting in the treatment of neurodegenerative diseases: an up-to-date perspective.

Nayab D, Din F, Ali H, Kausar W, Urooj S, Zafar M J Nanobiotechnology. 2023; 21(1):477.

PMID: 38087359 PMC: 10716964. DOI: 10.1186/s12951-023-02250-1.

Concept for a Unidirectional Release Mucoadhesive Buccal Tablet for Oral Delivery of Antidiabetic Peptide Drugs Such as Insulin, Glucagon-like Peptide 1 (GLP-1), and their Analogs.

Pratap-Singh A, Guo Y, Baldelli A, Singh A Pharmaceutics. 2023; 15(9).

PMID: 37765234 PMC: 10534625. DOI: 10.3390/pharmaceutics15092265.

Discovery of a New Chalcone-Trimethoxycinnamide Hybrid with Antimitotic Effect: Design, Synthesis, and Structure-Activity Relationship Studies.

Moreira J, Silva P, Barros M, Saraiva L, Pinto M, Bousbaa H Pharmaceuticals (Basel). 2023; 16(6).

PMID: 37375826 PMC: 10303900. DOI: 10.3390/ph16060879.

References

Kaminskas L, Boyd B, Porter C . Dendrimer pharmacokinetics: the effect of size, structure and surface characteristics on ADME properties. Nanomedicine (Lond). 2011; 6(6):1063-84. DOI: 10.2217/nnm.11.67. View

Liu Y, Zhang P, Feng N, Zhang X, Wu S, Zhao J . Optimization and in situ intestinal absorption of self-microemulsifying drug delivery system of oridonin. Int J Pharm. 2008; 365(1-2):136-42. DOI: 10.1016/j.ijpharm.2008.08.009. View

Zhao L, Feng S . Enhanced oral bioavailability of paclitaxel formulated in vitamin E-TPGS emulsified nanoparticles of biodegradable polymers: in vitro and in vivo studies. J Pharm Sci. 2010; 99(8):3552-60. DOI: 10.1002/jps.22113. View

Xie H, Smith J . Fabrication of PLGA nanoparticles with a fluidic nanoprecipitation system. J Nanobiotechnology. 2010; 8:18. PMC: 2929212. DOI: 10.1186/1477-3155-8-18. View

de Jong W, Borm P . Drug delivery and nanoparticles:applications and hazards. Int J Nanomedicine. 2008; 3(2):133-49. PMC: 2527668. DOI: 10.2147/ijn.s596. View

Stewart J, Artime M, OBrian C . Resveratrol: a candidate nutritional substance for prostate cancer prevention. J Nutr. 2003; 133(7 Suppl):2440S-2443S. DOI: 10.1093/jn/133.7.2440S. View

Teskac K, Kristl J . The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol. Int J Pharm. 2009; 390(1):61-9. DOI: 10.1016/j.ijpharm.2009.10.011. View

Ginkel P, Sareen D, Subramanian L, Walker Q, Darjatmoko S, Lindstrom M . Resveratrol inhibits tumor growth of human neuroblastoma and mediates apoptosis by directly targeting mitochondria. Clin Cancer Res. 2007; 13(17):5162-9. DOI: 10.1158/1078-0432.CCR-07-0347. View

Shvedova A, Castranova V, Kisin E, Schwegler-Berry D, Murray A, Gandelsman V . Exposure to carbon nanotube material: assessment of nanotube cytotoxicity using human keratinocyte cells. J Toxicol Environ Health A. 2003; 66(20):1909-26. DOI: 10.1080/713853956. View

10.

Tsan M, White J, Maheshwari J, Chikkappa G . Anti-leukemia effect of resveratrol. Leuk Lymphoma. 2002; 43(5):983-7. DOI: 10.1080/10428190290021669. View

11.

Kapadia G, Azuine M, Tokuda H, Takasaki M, Mukainaka T, Konoshima T . Chemopreventive effect of resveratrol, sesamol, sesame oil and sunflower oil in the Epstein-Barr virus early antigen activation assay and the mouse skin two-stage carcinogenesis. Pharmacol Res. 2002; 45(6):499-505. DOI: 10.1006/phrs.2002.0992. View

12.

Lin W, Huang Y, Zhou X, Ma Y . In vitro toxicity of silica nanoparticles in human lung cancer cells. Toxicol Appl Pharmacol. 2006; 217(3):252-9. DOI: 10.1016/j.taap.2006.10.004. View

13.

Oi N, Jeong C, Nadas J, Cho Y, Pugliese A, Bode A . Resveratrol, a red wine polyphenol, suppresses pancreatic cancer by inhibiting leukotriene A₄hydrolase. Cancer Res. 2010; 70(23):9755-64. PMC: 4872628. DOI: 10.1158/0008-5472.CAN-10-2858. View

14.

Hsieh W, Chang S, Chen H, Chen J, Liaw J . Oral gene delivery with cyclo-(D-Trp-Tyr) peptide nanotubes. Mol Pharm. 2012; 9(5):1231-49. DOI: 10.1021/mp200523n. View

15.

Merisko-Liversidge E, Liversidge G, Cooper E . Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur J Pharm Sci. 2003; 18(2):113-20. DOI: 10.1016/s0928-0987(02)00251-8. View

16.

Choi A, Cho S, Desbarats J, Lovric J, Maysinger D . Quantum dot-induced cell death involves Fas upregulation and lipid peroxidation in human neuroblastoma cells. J Nanobiotechnology. 2007; 5:1. PMC: 1802956. DOI: 10.1186/1477-3155-5-1. View

17.

Buxton D, Lee S, Wickline S, Ferrari M . Recommendations of the National Heart, Lung, and Blood Institute Nanotechnology Working Group. Circulation. 2003; 108(22):2737-42. DOI: 10.1161/01.CIR.0000096493.93058.E8. View

18.

Sayes C, Liang F, Hudson J, Mendez J, Guo W, Beach J . Functionalization density dependence of single-walled carbon nanotubes cytotoxicity in vitro. Toxicol Lett. 2005; 161(2):135-42. DOI: 10.1016/j.toxlet.2005.08.011. View

19.

Derfus A, Chan W, Bhatia S . Probing the Cytotoxicity Of Semiconductor Quantum Dots. Nano Lett. 2017; 4(1):11-18. PMC: 5588688. DOI: 10.1021/nl0347334. View

20.

Mecke A, Uppuluri S, Sassanella T, Lee D, Ramamoorthy A, Baker Jr J . Direct observation of lipid bilayer disruption by poly(amidoamine) dendrimers. Chem Phys Lipids. 2004; 132(1):3-14. DOI: 10.1016/j.chemphyslip.2004.09.001. View